Impact of new treatment options for hepatitis C virus infection in liver transplantation
出版年份 2015 全文链接
标题
Impact of new treatment options for hepatitis C virus infection in liver transplantation
作者
关键词
-
出版物
WORLD JOURNAL OF GASTROENTEROLOGY
Volume 21, Issue 38, Pages 10760
出版商
Baishideng Publishing Group Inc.
发表日期
2015-10-14
DOI
10.3748/wjg.v21.i38.10760
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Therapy with boceprevir or telaprevir in HIV/hepatitis C virus co-infected patients to treat recurrence of hepatitis C virus infection after liver transplantation
- (2015) Teresa Maria Antonini et al. AIDS
- Drug Interactions With Direct-Acting Antivirals for Hepatitis C
- (2015) Sarah Burgess et al. ANNALS OF PHARMACOTHERAPY
- Efficacy of Ledipasvir and Sofosbuvir, With or Without Ribavirin, for 12 Weeks in Patients With HCV Genotype 3 or 6 Infection
- (2015) Edward J. Gane et al. GASTROENTEROLOGY
- Sofosbuvir and Ribavirin for Treatment of Compensated Recurrent Hepatitis C Virus Infection After Liver Transplantation
- (2015) Michael Charlton et al. GASTROENTEROLOGY
- Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease
- (2015) Michael Charlton et al. GASTROENTEROLOGY
- Sofosbuvir with peginterferon-ribavirin for 12 weeks in previously treated patients with hepatitis C genotype 2 or 3 and cirrhosis
- (2015) Eric Lawitz et al. HEPATOLOGY
- Ledipasvir-sofosbuvir plus ribavirin for patients with genotype 1 hepatitis C virus previously treated in clinical trials of sofosbuvir regimens
- (2015) David Wyles et al. HEPATOLOGY
- Multicenter experience using simeprevir and sofosbuvir with or without ribavirin to treat hepatitis C genotype 1 after liver transplant
- (2015) Surakit Pungpapong et al. HEPATOLOGY
- Sofosbuvir compassionate use program for patients with severe recurrent hepatitis C after liver transplantation
- (2015) Xavier Forns et al. HEPATOLOGY
- Virologic Response Following Combined Ledipasvir and Sofosbuvir Administration in Patients With HCV Genotype 1 and HIV Co-infection
- (2015) Anu Osinusi et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Daclatasvir in Combination With Asunaprevir and Beclabuvir for Hepatitis C Virus Genotype 1 Infection With Compensated Cirrhosis
- (2015) Andrew J. Muir et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Ombitasvir, Paritaprevir Co-dosed With Ritonavir, Dasabuvir, and Ribavirin for Hepatitis C in Patients Co-infected With HIV-1
- (2015) Mark S. Sulkowski et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Outcome and management of HCV/HIV coinfection pre- and post-liver transplantation. A 2015 update
- (2015) Jose M. Miro et al. JOURNAL OF HEPATOLOGY
- Pegylated interferon plus ribavirin in HIV-infected patients with recurrent hepatitis C after liver transplantation: A prospective cohort study
- (2015) Lluis Castells et al. JOURNAL OF HEPATOLOGY
- EASL Recommendations on Treatment of Hepatitis C 2015
- (2015) JOURNAL OF HEPATOLOGY
- Superior outcomes in HIV–positive kidney transplant patients compared with HCV–infected or HIV/HCV–coinfected recipients
- (2015) Deirdre Sawinski et al. KIDNEY INTERNATIONAL
- Efficacy and safety of 8 weeks versus 12 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin in patients with hepatitis C virus genotype 1 mono-infection and HIV/hepatitis C virus co-infection (C-WORTHY): a randomised, open-label phase 2 trial
- (2015) Mark Sulkowski et al. LANCET
- Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS)
- (2015) Marc Bourlière et al. LANCET INFECTIOUS DISEASES
- Sofosbuvir and simeprevir for treatment of hepatitis C virus infection in liver transplant recipients
- (2015) Julio A. Gutierrez et al. LIVER TRANSPLANTATION
- Antiretroviral blood levels in HIV/HCV-coinfected patients with cirrhosis after liver transplant: a report of three cases
- (2015) E. Righi et al. Transplant Infectious Disease
- Telaprevir- and Boceprevir-based Triple Therapy for Hepatitis C in Liver Transplant Recipients With Advanced Recurrent Disease
- (2015) Elizabeth C. Verna et al. TRANSPLANTATION
- Re-treatment of Chronic Hepatitis C Virus Genotype 1 Infection After Relapse
- (2014) Anu Osinusi et al. ANNALS OF INTERNAL MEDICINE
- Sofosbuvir plus daclatasvir for post-transplant recurrent hepatitis C: Potent antiviral activity but no clinical benefit if treatment is given late
- (2014) Adriano M. Pellicelli et al. DIGESTIVE AND LIVER DISEASE
- Efficacy of new direct acting antivirals in transplant recipients and patients with advanced disease
- (2014) Sabela Lens et al. DIGESTIVE AND LIVER DISEASE
- Overall efficacy and safety results of sofosbuvir-based therapies in Phase II and III studies
- (2014) Alessandra Mangia et al. DIGESTIVE AND LIVER DISEASE
- ABT-450, Ritonavir, Ombitasvir, and Dasabuvir Achieves 97% and 100% Sustained Virologic Response With or Without Ribavirin in Treatment-Experienced Patients With HCV Genotype 1b Infection
- (2014) Pietro Andreone et al. GASTROENTEROLOGY
- Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study
- (2014) Eric Lawitz et al. LANCET
- High post-transplant virological response in hepatitis C virus infected patients treated with pretransplant protease inhibitor-based triple therapy
- (2014) Elizabeth C. Verna et al. LIVER INTERNATIONAL
- An Interferon-free Antiviral Regimen for HCV after Liver Transplantation
- (2014) Paul Y. Kwo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Retreatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin
- (2014) Stefan Zeuzem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection
- (2014) Nezam Afdhal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sofosbuvir and Ribavirin in HCV Genotypes 2 and 3
- (2014) Stefan Zeuzem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis
- (2014) Kris V. Kowdley et al. NEW ENGLAND JOURNAL OF MEDICINE
- ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis
- (2014) Fred Poordad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pros and cons of liver transplantation in human immunodeficiency virus infected recipients
- (2014) Umberto Baccarani WORLD JOURNAL OF GASTROENTEROLOGY
- Sofosbuvir and Ribavirin for Hepatitis C Genotype 1 in Patients With Unfavorable Treatment Characteristics
- (2013) Anuoluwapo Osinusi et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Safety and efficacy of protease inhibitors to treat hepatitis C after liver transplantation: A multicenter experience
- (2013) Audrey Coilly et al. JOURNAL OF HEPATOLOGY
- Long-term clearance of hepatitis C virus following interferon α-2b or peginterferon α-2b, alone or in combination with ribavirin
- (2013) M. P. Manns et al. JOURNAL OF VIRAL HEPATITIS
- Multicenter experience using telaprevir or boceprevir with peginterferon and ribavirin to treat hepatitis C genotype 1 after liver transplantation
- (2013) Surakit Pungpapong et al. LIVER TRANSPLANTATION
- Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options
- (2013) Ira M. Jacobson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
- (2013) Eric Lawitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Feasibility of Telaprevir-Based Triple Therapy in Liver Transplant Patients with Hepatitis C Virus: SVR 24 Results
- (2013) Christoph R. Werner et al. PLoS One
- Genotype and Subtype Profiling of PSI-7977 as a Nucleotide Inhibitor of Hepatitis C Virus
- (2012) Angela M. Lam et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Liver transplantation in the setting of chronic HCV
- (2012) Norah Terrault BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- A randomized controlled trial of pretransplant antiviral therapy to prevent recurrence of hepatitis C after liver transplantation
- (2012) Gregory T. Everson et al. HEPATOLOGY
- 1130 THE EFFECT OF HEPATIC IMPAIRMENT ON THE PHARMACOKINETICS AND ANTIVIRAL ACTIVITY OF PSI-7977 IN HEPATITIS C INFECTED SUBJECTS TREATED FOR SEVEN DAYS
- (2012) E. Lawitz et al. JOURNAL OF HEPATOLOGY
- 202 USE OF TELAPREVIR PLUS PEG INTERFERON/RIBAVIRIN FOR NULL RESPONDERS POST OLT WITH ADVANCED FIBROSIS/CHOLESTATIC HEPATITIS C
- (2012) P. Kwo et al. JOURNAL OF HEPATOLOGY
- Projected future increase in aging hepatitis C virus-infected liver transplant candidates: A potential effect of hepatocellular carcinoma
- (2012) Scott W. Biggins et al. LIVER TRANSPLANTATION
- A Sustained Virologic Response Reduces Risk of All-Cause Mortality in Patients With Hepatitis C
- (2011) Lisa I. Backus et al. Clinical Gastroenterology and Hepatology
- A prospective study of the rate of progression in compensated, histologically advanced chronic hepatitis C
- (2011) Jules L. Dienstag et al. HEPATOLOGY
- An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases
- (2011) Marc G. Ghany et al. HEPATOLOGY
- Epidemiology and outcome of infections in human immunodeficiency virus/hepatitis c virus-coinfected liver transplant recipients: A FIPSE/GESIDA Prospective Cohort Study
- (2011) Asunción Moreno et al. LIVER TRANSPLANTATION
- Boceprevir for Untreated Chronic HCV Genotype 1 Infection
- (2011) Fred Poordad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Response-Guided Telaprevir Combination Treatment for Hepatitis C Virus Infection
- (2011) Kenneth E. Sherman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection
- (2011) Bruce R. Bacon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
- (2011) Ira M. Jacobson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interleukin-28B polymorphisms are associated with histological recurrence and treatment response following liver transplantation in patients with hepatitis C virus infection
- (2010) Michael R. Charlton et al. HEPATOLOGY
- Discovery of a β-d-2′-Deoxy-2′-α-fluoro-2′-β-C-methyluridine Nucleotide Prodrug (PSI-7977) for the Treatment of Hepatitis C Virus
- (2010) Michael J. Sofia et al. JOURNAL OF MEDICINAL CHEMISTRY
- Extrahepatic hepatitis C virus after transplantation: Diabetes and renal dysfunction
- (2010) Sabina Sabharwal et al. LIVER TRANSPLANTATION
- The natural history of recurrent hepatitis C and what influences this
- (2010) Edward J. Gane LIVER TRANSPLANTATION
- Individualized Extension of Pegylated Interferon Plus Ribavirin Therapy for Recurrent Hepatitis C Genotype 1b After Living-Donor Liver Transplantation
- (2010) Yoshihide Ueda et al. TRANSPLANTATION
- Insulin Resistance, Serum Adipokines and Risk of Fibrosis Progression in Patients Transplanted for Hepatitis C
- (2009) B. J. Veldt et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Efficacy and safety of peginterferon alfa-2a (40KD) plus ribavirin in hepatitis C patients with advanced fibrosis and cirrhosis
- (2009) Savino Bruno et al. HEPATOLOGY
- The global burden of hepatitis C
- (2009) Daniel Lavanchy LIVER INTERNATIONAL
- Natural history of postâliver transplantation hepatitis C: A review of factors that may influence its course
- (2009) Juan F. Gallegos-Orozco et al. LIVER TRANSPLANTATION
- The natural history of hepatitis C cirrhosis after liver transplantation
- (2009) Roberto J. Firpi et al. LIVER TRANSPLANTATION
- Pre-emptive antiviral therapy in living donor liver transplantation for hepatitis C: observation based on a single-center experience
- (2009) Sumihito Tamura et al. TRANSPLANT INTERNATIONAL
- Clinical Benefits of Antiviral Therapy in Patients with Recurrent Hepatitis C Following Liver Transplantation
- (2008) M. Berenguer et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Therapeutical Aspects and Outcome of HIV/HCV Coinfected Patients Treated with Pegylated Interferon plus Ribavirin in an Italian Cohort
- (2008) E. Righi et al. INFECTION
- Antiviral therapy increases the risk of bacterial infections in HCV-infected cirrhotic patients awaiting liver transplantation: A retrospective study
- (2008) Jose A. Carrión et al. JOURNAL OF HEPATOLOGY
- The significance of metabolic syndrome in the setting of recurrent hepatitis C after liver transplantation
- (2008) Ibrahim A. Hanouneh et al. LIVER TRANSPLANTATION
- Mortality related to chronic hepatitis B and chronic hepatitis C in France: Evidence for the role of HIV coinfection and alcohol consumption
- (2007) Patrick Marcellin et al. JOURNAL OF HEPATOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started